Igyxos Company
.jpg)
Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.
Total Funding:
$8,530,579
Headquarters:
Nouzilly, Centre, France
Funding Status:
Early Stage Venture
Employee Number:
1-10
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Last Funding Date:
2019-03-21
Investors Number:
3
Founded Date:
01-01-2017
Industry:
Reproductive Health & Contraception